User:Mr. Ibrahem/Temsirolimus

Temsirolimus, sold under the brand name Torisel, is a medication used to treat renal cell carcinoma (RCC) and mantle cell lymphoma. It is given by gradual injection into a vein. It is generally used together with an antihistamine such as diphenhydramine.

Common side effects include infections such as pneumonia, low platelets, low red blood cells, high blood sugar, difficulty breathing, vomiting, rash, swelling, tiredness, and fever. Serious side effects may include allergies, pulmonary embolism, and high blood fat. It is converted in the body to sirolimus; which works by blocking a protein called mTOR.

Temsirolimus was approved for medical use in the United States and Europe in 2007. In the United States it costs about 1,900 USD per 25 mg dose as of 2021. This amount in the United Kingdom costs the NHS about £620.